688098 申聯生物
按盤價 
4.020 +0.050 (+1.259%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.149 | 2.111 | 4.107 | 7.665 | 9.670 |
| 總資產報酬率 ROA (%) | -0.139 | 1.970 | 3.815 | 7.080 | 8.745 |
| 投入資產回報率 ROIC (%) | -0.148 | 2.098 | 4.079 | 7.603 | 9.287 | 邊際利潤分析 |
| 銷售毛利率 (%) | 61.023 | 70.833 | 75.229 | 75.731 | 83.687 |
| 營業利潤率 (%) | -3.969 | 11.980 | 22.896 | 35.903 | 43.642 |
| 息稅前利潤/營業總收入 (%) | -4.099 | 11.721 | 22.398 | 34.704 | 43.748 |
| 淨利潤/營業總收入 (%) | -3.549 | 9.901 | 18.556 | 29.144 | 38.305 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 50.237 | 85.004 | 103.279 | 90.138 | 84.436 |
| 價值變動淨收益/利潤總額(%) | -16.750 | 15.960 | 4.442 | 9.590 | 10.216 |
| 營業外收支淨額/利潤總額(%) | 0.204 | 0.403 | -0.917 | -2.148 | 1.733 | 償債能力分析 |
| 流動比率 (X) | 7.558 | 7.820 | 7.257 | 6.461 | 7.498 |
| 速動比率 (X) | 6.160 | 6.359 | 6.071 | 5.550 | 6.826 |
| 資產負債率 (%) | 5.659 | 5.453 | 6.742 | 7.850 | 7.805 |
| 帶息債務/全部投入資本 (%) | -0.039 | -0.168 | 0.018 | -0.191 | -- |
| 股東權益/帶息債務 (%) | -256,793.368 | -59,367.630 | 540,213.360 | -51,981.356 | 66,608.363 |
| 股東權益/負債合計 (%) | 1,647.921 | 1,712.637 | 1,383.268 | 1,178.606 | 1,181.363 |
| 利息保障倍數 (X) | 33.847 | -38.060 | -77.237 | -78.109 | -65.901 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 300.164 | 296.208 | 204.417 | 141.782 | 0.000 |
| 存貨周轉天數 (天) | 293.415 | 464.908 | 483.748 | 361.281 | 0.000 |
| 備註： | 即時報價更新時間為 09/07/2024 09:43 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
